Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

SomaLogic, Inc. Class A Common Stock (SLGC)

Services-commercial Physical & Biological Research

https://www.somalogic.com

SomaLogic is a commercial-stage proteomics company. It operates as a protein biomarker discovery and clinical diagnostics company that develops slow off-rate modified aptamers, which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. The Somamers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

C/O SOMALOGIC, INC., 2945 WILDERNESS PLACE
BOULDER, CO

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/15/2021

Market Cap

396,225,917

Shares Outstanding

188,680,000

Weighted SO

188,679,133

Total Employees

N/A

Upcoming Earnings

03/26/2024

Beta

1.6390

Last Div

0.0000

Range

1.73-3.79

Chg

-0.1000

Avg Vol

2268458

Mkt Cap

396225917

Exch

NASDAQ

Country

US

Phone

303 625 9000

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

4.8483

EV Multiple

-0.6718

P/FV

0.7909

Div Yield %

0.0000

P/E

-3.0131

PEG

-0.4746

Payout

0.0000

Current Ratio

17.7857

Quick Ratio

17.0815

Cash Ratio

10.9993

DSO

92.5854

DIO

105.3765

Op Cycle

197.9619

DPO

86.9637

CCC

110.9982

Gross Margin

0.4115

Op Margin

-1.8826

Pretax Margin

-1.5907

Net Margin

-1.5954

Eff Tax Rate

-0.0030

ROA

-0.2307

ROE

-0.2472

ROCE

-0.2864

NI/EBT

1.0030

EBT/EBIT

0.8449

EBIT/Rev

-1.8826

Debt Ratio

0.0241

D/E

0.0274

LT Debt/Cap

0.0055

Total Debt/Cap

0.0266

Int Coverage

2.3732

CF/Debt

-9.2239

Equity Multi

1.1375

Rec Turnover

3.9423

Pay Turnover

4.1972

Inv Turnover

3.4638

FA Turnover

4.4972

Asset Turnover

0.1446

OCF/Share

-0.6702

FCF/Share

-0.6516

Cash/Share

2.4259

OCF/Sales

-1.5341

FCF/OCF

0.9723

CF Coverage

-9.2239

ST Coverage

-11.5773

CapEx Coverage

-36.0365

Div&CapEx Cov

-36.0365

P/BV

0.7909

P/B

0.7909

P/S

4.8483

P/E

-3.0131

P/FCF

-3.2506

P/OCF

-3.1335

P/CF

-3.1335

PEG

-0.4746

P/S

4.8483

EV Multiple

-0.6718

P/FV

0.7909

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools GlobeNewswire Inc. Dec 22, 18:47 ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools Benzinga Dec 15, 12:46 Why Quanex Building Products Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session GlobeNewswire Inc. Oct 31, 16:30 SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023

Revenue Product Segmentation